News
Danish pharmaceutical company Novo Nordisk has officially launched its once-weekly injectable weight management drug, Wegovy® (semaglutide 2.4mg), in Singapore. The treatment received regulatory ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
A long-term investor in Apple (AAPL) might be perfectly thrilled at the stock's performance. It has returned 663% over the past 10 years, compared with a return of 261% for the S&P 500 SPX. And ...
When Amy Schumer realized Ozempic and Wegovy had harmful side effects for her, she didn’t let that deter her from trying other prescriptions to lose ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
Explore more
Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and nutrition.
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...
Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results